14-day Premium Trial Subscription Try For FreeTry Free
$3.42
+0.0800 (+2.40%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 CLRB stock ended at $3.42. This is 2.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.09% from a day low at $3.34 to a day high of $3.51.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Dec 13, 2021 $0.790 $0.790 $0.720 $0.720 556 176
Dec 10, 2021 $0.720 $0.779 $0.720 $0.777 413 897
Dec 09, 2021 $0.770 $0.770 $0.700 $0.732 294 634
Dec 08, 2021 $0.701 $0.773 $0.670 $0.762 428 684
Dec 07, 2021 $0.650 $0.710 $0.640 $0.695 867 551
Dec 06, 2021 $0.620 $0.651 $0.582 $0.644 376 083
Dec 03, 2021 $0.670 $0.700 $0.604 $0.611 537 227
Dec 02, 2021 $0.660 $0.670 $0.620 $0.656 441 327
Dec 01, 2021 $0.688 $0.700 $0.660 $0.660 299 087
Nov 30, 2021 $0.690 $0.698 $0.660 $0.691 471 422
Nov 29, 2021 $0.721 $0.770 $0.680 $0.692 271 405
Nov 26, 2021 $0.743 $0.750 $0.700 $0.723 198 211
Nov 24, 2021 $0.744 $0.780 $0.720 $0.750 218 482
Nov 23, 2021 $0.750 $0.796 $0.720 $0.724 404 726
Nov 22, 2021 $0.750 $0.778 $0.695 $0.768 715 421
Nov 19, 2021 $0.80 $0.82 $0.752 $0.755 398 853
Nov 18, 2021 $0.83 $0.84 $0.775 $0.791 367 723
Nov 17, 2021 $0.791 $0.84 $0.790 $0.84 482 533
Nov 16, 2021 $0.84 $0.88 $0.790 $0.80 601 185
Nov 15, 2021 $0.88 $0.88 $0.83 $0.84 377 951
Nov 12, 2021 $0.86 $0.88 $0.86 $0.87 84 340
Nov 11, 2021 $0.88 $0.89 $0.86 $0.86 321 271
Nov 10, 2021 $0.92 $0.94 $0.86 $0.87 534 239
Nov 09, 2021 $0.93 $0.94 $0.91 $0.91 413 505
Nov 08, 2021 $0.97 $0.97 $0.92 $0.94 275 271
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT